<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The molecular mechanism of <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> is a multistep process that is characterized by both activation of oncogenes and inactivation of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor genes </plain></SENT>
<SENT sid="1" pm="."><plain>In the present study, mutations of N-ras, p53 and FMS-like tyrosine kinase 3 (FLT-3) genes and loss of expression of the deleted in colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> (<z:chebi fb="8" ids="53090">DCC</z:chebi>) gene were analyzed in 59 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>Mutations of N-ras, p53, and FLT-3 genes were detected in 7, 7, 1 of the 59 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>Loss of <z:chebi fb="8" ids="53090">DCC</z:chebi> expression was detected in 16 patients </plain></SENT>
<SENT sid="4" pm="."><plain>Type of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients with N-ras mutation were <z:hpo ids='HP_0000001'>all</z:hpo> <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess of blasts in transformation (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB-T</z:e>) </plain></SENT>
<SENT sid="5" pm="."><plain>Abnormalities of p53 and <z:chebi fb="8" ids="53090">DCC</z:chebi> genes were significantly associated with survival time (p&lt; 0.02, p&lt; 0.004, respectively) </plain></SENT>
</text></document>